Combining exercise and transcranial direct current stimulation to improve movement in Parkinson's disease
Official title: Effects of the Combination of Physical Exercise and Transcranial Direct Current Stimulation on Motor Function and Underlying Neurophysiological Mechanisms in Parkinson's Disease
Run by Universidad Rey Juan Carlos · NCT07524400 · Data updated 2026-11-12
We will test whether adding transcranial direct current stimulation (tDCS) to exercise helps improve movement in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Universidad Rey Juan Carlos Academic / other |
| Locations | 1 site (Fuenlabrada, Madrid) |
| Status | Recruiting |
| Started | May 10, 2026 |
| Main results expected | August 1, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07524400 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people with idiopathic Parkinson's disease (per UK Brain Bank criteria) who can follow study procedures, are on a stable antiparkinsonian medication regimen, and do not have significant cognitive impairment or contraindicating medical conditions.
✕Probably not a fit
Patients with marked cognitive impairment, clinically significant depression, history of seizures, cardiac pacemakers, uncontrolled medical conditions, or current cholinesterase inhibitor treatment are unlikely to be eligible and may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, blinded, controlled trial will compare real tDCS plus exercise, sham tDCS plus exercise, and exercise alone in a large sample of people with idiopathic Parkinson's disease. Participants on stable antiparkinsonian medication who meet cognitive and medical safety criteria will complete supervised exercise sessions with concurrent tDCS or sham stimulation at the Center of Sport Research in Fuenlabrada, Madrid. Motor outcomes will be measured before and after the intervention using clinical scales, and EEG and transcranial magnetic stimulation will probe changes in cortical excitability, motor preparation, and synaptic plasticity. The design aims both to see if tDCS potentiates exercise-related motor gains and to clarify underlying neurophysiological mechanisms.
Why it matters
Potential benefit: If successful, combining tDCS with exercise could produce greater and longer-lasting improvements in motor function and daily activities for people with Parkinson's disease.
How similar studies have gone: A few small, heterogeneous studies suggest possible benefit from combining tDCS with exercise, but the existing evidence is limited and methodologically inconsistent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Clinical diagnosis of idiopathic Parkinson's disease, established according to the UK Parkinson's Disease Society Brain Bank Criteria. Ability to understand and comply with study procedures. Stable antiparkinsonian medication regimen prior to study participation. Exclusion Criteria: Significant cognitive impairment, defined as a score \< 23 on the Mini-Mental State Examination (MMSE). Below-average premorbid intelligence, defined as a score \< 40 on the Vocabulary subtest of the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Clinically significant depression, defined as a score \> 10 on the Geriatric Depression Scale (GDS-15). Current treatment with cholinesterase inhibitors. Presence of severe cardiovascular disease, including but not limited to: Congestive heart failure Ischemic heart disease Cardiac pacemaker Orthostatic hypotension Uncontrolled diabetes mellitus. History of stroke or traumatic brain injury. History of seizure disorder or epilepsy. Presence or prior implantation of a deep brain stimulation (DBS) device. History of major orthopedic surgery that could interfere with motor performance or gait. Presence of implanted electronic devices, including cardiac pacemakers, incompatible with study procedures.
Where it's running
-
Center of Sport Research
Fuenlabrada, Madrid, Spain Recruiting
Study contacts
- Principal investigator: Miguel Angel Fernández del Olmo, PhD — Universidad Rey Juan Carlos
- Study coordinator: Eduardo Villamil Cabell, PhD
- Email: eduardo.villamil@urjc.es
- Phone: +34 666 66 81 05
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.